Are you Dr. Sanabria?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
525 S. Silverbrook Dr.
West Bend, WI 53095Phone+1 262-334-6020Fax+1 262-334-6067
Summary
- Dr. Carlos Sanabria, MD is a board certified internist in West Bend, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Illinois. He is affiliated with Aurora West Allis Medical Center.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1991 - 1992
- Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1984 - 1988
- Medical College of WisconsinClass of 1984
Certifications & Licensure
- IL State Medical License 1986 - 2026
- WI State Medical License 1987 - 2025
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants Start of enrollment: 2012 Dec 27
- Open Label Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 in Healthy Volunteers Start of enrollment: 2013 Jan 01
- A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsEffect of Cefiderocol, a Siderophore Cephalosporin, on QT/QTc Interval in Healthy Adult SubjectsCarlos Sanabria, Elizabeth Migoya, Jay W. Mason, Stephanie H. Stanworth, Takayuki Katsube
Clinical Therapeutics. 2019-08-01 - 169 citationsEffect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.Murali K. Matta, Robbert Zusterzeel, Nageswara Rao Pilli, Vikram Patel, Donna A. Volpe
JAMA. 2019-06-04 - 60 citationsAssessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study.Jose Vicente, Robbert Zusterzeel, Lars Johannesen, Roberto Ochoa‐Jimenez, Jay W. Mason
Clinical Pharmacology and Therapeutics. 2019-04-01